Resultados de la búsqueda 211-220 of 753 for visual+hallucinations

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study will also test what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    ... vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor ...

  5. Neurología - Ensayos clínicos - Mayo Clinic

    ... vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor ...

  6. Neurología - Ensayos clínicos

    ... vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor ...

  7. Ensayos clínicos - Neurología

    Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and ...

  8. Neurología - Ensayos clínicos - Mayo Clinic

    ... vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    ... vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come back (recurrent).